NIMBLE-CRC: NeoImmunoModulation Before Leveraging Excision in Colorectal Rectal Cancer
8d agoen
From the article
Conditions : Colon Cancer Metastatic Interventions : Drug: Retifanlimab; Drug: Zanzalintinib Sponsors : Northwell Health Not yet recruiting
Continue reading on clinicaltrials.govYou might also wanna read

T cell-myeloid reprogramming overcomes immune resistance in colorectal cancer models
This article presents a scientific study on colorectal cancer (CRC) immunotherapy resistance. It shows that during anti-PD-1 treatment, tumo
cell.com·27d ago

AI-guided discovery identifies GPNMB as promising CAR T cell target for multiple cancers
Researchers developed an AI-driven framework for discovering CAR T cell therapy targets by integrating single-cell RNA sequencing data from
cell.com·13d ago
Real-World EV Plus Pembro Success Seen in Urothelial Cancer
Medscape·23h ago
Protein-based pan-RAS inhibitor induces tumor regression in female mice via IFNγ and CD8+ T cell-dependent tumor necrosis
doi.org·19d ago

Comments
Sign in to join the conversation.
No comments yet. Be the first.